OPT101 is a small peptide (a type of protein) designed to target CD40, which plays a central role in the inflammatory autoimmune response that damages the insulin-producing beta cells in people with T1D. The drug is given by subcutaneous injection, meaning it is injected just under the skin, like insulin.
The researchers hypothesize that by regulating inflammation related ...
The researchers hypothesize that by regulating inflammation related ...